0001140361-26-036866 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2026 • Lisata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry Jurisdiction
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 17th, 2026 • Lisata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is dated as of September 17, 2026, by and between Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned signatories hereto.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 17th, 2026 • Lisata Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledSeptember 17th, 2026 Company IndustryTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 17, 2026, is entered into by and among Lisata Therapeutics, Inc., a Delaware corporation (the “Company”), and the several investors signatory hereto (individually as an “Investor” and collectively together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • September 17th, 2026 • Lisata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of September 17, 2026, by and among Lisata Therapeutics, Inc., a Delaware corporation (“Parent”), Mariner Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“First Merger Sub”), Mariner Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of Parent (“Second Merger Sub” and together with First Merger Sub, “Merger Subs”), and Marea Therapeutics, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
